MedTrace Logo

Effect of Phosphatidylcholine on Plasma Homocysteine in Healthy Volunteers

NCT00102232 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2005-06-24

No results posted yet for this study

Summary

The purpose of this study is to determine whether supplementation with phosphatidylcholine lowers plasma homocysteine concentrations in healthy men.

Conditions

Interventions

PROCEDURE

supplementation with phosphatidylcholine

Sponsors & Collaborators

  • Wageningen Centre for Food Sciences

    lead OTHER

Principal Investigators

  • Petra Verhoef, PhD · Wageningen Centre for Food Sciences

  • Elizabeth J Brink, PhD · TNO Nutrition and Food Research

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
71 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-05-31
Completion
2003-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00102232 on ClinicalTrials.gov